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A subpopulation of human bone marrow (B) lymphocytes stimulates the prolifer- 
ation of autologous thymus-derived  (T)  lymphocytes (1,  2).  This autologous mixed 
lymphocyte reaction (MLR) 1 has been shown to have two cardinal characteristics of 
an immune response, i.e., memory and specificity (3).  Furthermore, the autologous 
MLR has been shown to provide a proliferative stimulus required for the generation 
of cytotoxic lymphocytes (4). More recently, generation of suppressor cell activity has 
been demonstrated during this reaction (5, 6). This suggests a potential immunoreg- 
ulatory function for the autologous MLR. 
Infectious mononucleosis  (IM)  is  a  viral  disease  often  associated  with  transient 
autoimmune  phenomena  (7,  8).  These  studies  were  undertaken  to  correlate  the 
autologous MLR with disease activity during IM.  Patients with  acute IM  did not 
generate a  normal analogous MLR during the acute phase of the disease. However, 
the autologous MLR returned to normal levels during convalescence from IM. The 
cellular basis of the defect in the autologous MLR was shown to be a  result of the 
failure of B cells to stimulate autologous T  cells. 
Materials and Methods 
Patients Studied.  Nine patients with acute IM were studied. Patients were males and females 
between the ages of 18 and  27.  Diagnosis was based  upon  presentation  of fever, sore throat, 
lymphadenopathy,  a  positive heterophile  index, and  the presence of atypical  lymphocytes in 
the peripheral blood. Patients were untreated at the time of the study. Healthy young subjects 
without  evidence  of prior  immunity  to  rubella  virus,  as  determined  by  hemagglutination 
inhibition (HI), were inoculated with live attenuated rubella virus, HPV-77 (Meruvax, Merck, 
Sharp and Dohme, Div. of Merck & Co., Inc., West Point, Pa.). The autologous MLR of these 
individuals was examined from 3 to 21 d after inoculation. All subjects developed HI antibodies 
to rubella 2-4 mo after inoculation. 
Autologous and Allogeneic MLR Cultures.  The autologous and  allogeneic MLR cultures were 
established  as  previously described  (1).  Briefly, human  peripheral  blood T  lymphocytes that 
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tbrmed rosettes with sheep erythrocytes were separated from non-T lymphocytes. Throughout 
this report we use the term B lymphocyte to identify the nonrosetting B-cell-enriched population 
of cells, recognizing that this preparation is heterogeneous containing B cells, null cells, K cells, 
and  monocytes.  7%  of the  T-lymphocyte  preparation  and  93-98%  of  the  B-lymphocyte 
preparation reacted with fluorescinated anti-human immunoglobulin antibody.  15-35% of the 
mononuclearcells in the B-lymphocyte preparation pha§ocytized latex particles. Culture wells 
contained  10  purified  T  lymphocytes and  1-2  ×  I0  irradiated  (3,000  R)  autologous or 
allogeneic  B  lymphocytes in  0.2  RPMI-1640 with  20%  human  serum  from AB-type blood 
donors. Cultures were incubated 6 d. Thymidine incorporation was measured during the last 
24 h of incubation. The average of the counts per minute of triplicate cultures is given. 
Phytohemagglutinin Stimulation.  Each culture well contained 0.2 ml of final culture medium, 
1 ×  105 T  lymphocytes and,  where indicated,  2 #g phytohemagglutinin  (PHA)  (Burroughs- 
Wellcome Co., Research Triangle Park, N. (2.). (2uhures were established in triplicate, incubated 
for 4 d, and thymidine incorporation was measured during the last 24 h of culture. 
C~yopreservation.  The concentration ofT or B lymphocytes was adjusted to 6-12 ×  105 cells/ 
ml in RPMI-1640 supplemented with 50% heat-inactivated human AB serum at 4°C. An equal 
volume of media that contained 20% dimethyl sulfoxide (Fisher  Scientific Co., Pittsburgh, Pa.) 
was  slowly  added  to  the  cell  with  constant  mixing  at  4°(2.  Cells  were  then  aliquoted  to 
polypropylene screw-cap vials. The vials were gradually cooled to -70°C and finally transferred 
to a  liquid nitrogen storage unit.  (2ryopreserved cells  to be used  in assays were defrosted as 
follows: upon removal of vials from the liquid nitrogen storage unit, the contents were rapidly 
warmed to 37°(3  and diluted slowly with constant agitation with RPMI that contained 20% 
AB sera.  This suspension was then centrifuged and resuspended in media. Cell recovery from 
freezing varied from 80 to 90% based on trypan blue exclusion assays. 
Results 
Autologous and Allogeneic MLR in Patients with Acute IM.  T  lymphocytes from normal 
subjects or subjects with IM were cultured with irradiated  autologous or allogeneic B 
lymphocytes (Table  I). The autologous MLR  in patients  with  IM was severely and 
significantly  (P <  0.001)  depressed  when  compared  with  the  autologous  MLR  in 
normal subjects.  In contrast to the depressed  autologous MLR, the allogeneic MLR 
in  patients  with  IM  was  equal  to  the  allogeneic  MLR  generated  by  healthy  age- 
matched  controls. Thus, T  lymphocytes from these individuals  respond  normally to 
allogeneic  B  lymphocytes  but  poorly  or  not  at  all  to  autologous  B  lymphocytes. 
Although, B  lymphocytes from eight  patients  with  IM stimulated  thymidine  incor- 
poration  by allogeneic T  lymphocytes less well  (32.5  -+  7.0  ×  103 cpm)  than  did  B 
lymphocytes from eight  normal  subjects  (44.5  _  13.0  ×  10  a cpm),  these  results  did 
not reach statistical  significance  (0.05 <  P  <  0.1). T  lymphocytes from patients with 
IM cultured alone incorporated more thymidine than did T  lymphocytes from normal 
individuals,  but this difference was not statistically significant.  As has been reported 
previously, the response to the T-cell mitogen PHA, was depressed  during the acute 
phase of IM (Table I). The response of patients with IM was ~30% of the response of 
control subjects  (P <  0.01).  Because the patients with IM studied  had a  self-limited 
disease, we were next able to determine  if the normal autologous MLR  was restored 
during convalescence. 
Recovery of the Autologous MLR during Convalescence.  The autologous MLR was tested 
4-16 wk after diagnosis when the patients had recovered from acute IM (Fig.  1). All 
seven patients had a significantly impaired autologous MLR at the time of diagnosis. 
In these patients  the autologous MLR  was depressed  by >85%.  Nevertheless,  six of 
the  seven  regained  a  normal  autologous  MLR  within  16  wk  of  diagnosis.  The 1450  AUTOLOGOUS  MIXED  LYMPHOCYTE  REACTIVITY  IN  MONONUCLEOSIS 
TASLE  I 
Impaired Autologous MLR in Patients with IM* 
T-lym- 
phocyte 
donor 
Stimulus 
Autologous B  Allogeneic B lym-  PHA 
lymphocyte  phocyte 
cpm/culture  ×  10 -3 
Normal (9)  t6.3 ±  1.7  43.2 ±  11.5  48.2  ±  15.6 
IM (9)  2.2 --. 0.8  43.6  +  7.7  15.8 ±  5.6 
* 105 lymphocytes were incubated with an equal number of irradiated  autol- 
ogous or allogeneic B lymphocytes or 10 ~g/ml PHA in 0.2  ml RPMI-1640 
with 20% human AB serum. Tritiated thymidine incorporation was measured 
during the last  24  h  of culture. Cultures were incubated a  total  of 6  d  for 
MLR  responses and  4  d  for PHA  responses. The background counts per 
minute (T lymphocytes cultured with irradiated autologous T  lymphocytes) 
averaged  584  cpm for IM patients and  240  cpm for normal subjects. The 
data are presented as the mean ±  SE. 
autologous MLR in one individual increased during convalescence, but did not reach 
the normal range within  16 wk. 
These studies did not distinguish between a failure of T  cells to respond or a failure 
of  B  cells  to  stimulate  an  autologous  MLR.  This  question  was  investigated  by 
comparing the  properties of cryopreserved lymphocytes obtained  during  the  acute 
phase of the disease with lymphocytes obtained during convalescence. 
Cellular  basis  of the  impaired  autologous  MLR  in  patients  with  IM.  To  distinguish 
between a failure ofT cells to respond or a failure of B lymphocytes to stimulate, the 
autologous  MLR  was  measured  in  four  patients  during  convalescence when  their 
autologous MLR had returned  to normal. At that  time the capacity of acute-phase 
cryopreserved T  cells to respond or acute-phase cryopreserved B cells to stimulate an 
autologous MLR was studied  (Table II). As expected, in all four subjects, cryopres- 
erved  lymphocytes obtained  during  the  acute  phase  of IM  failed  to  generate  an 
autologous MLR whereas convalescent lymphocytes demonstrated normal reactivity. 
Convalescent B cells stimulated both acute-phase and convalescent T  cells equally. In 
contrast,  acute-phase B cells did not stimulate either acute-phase or convalescent T 
cells.  These results suggest that the impaired autologous MLR in patients with acute 
IM  results  from the  failure of the  B-cell  population  to stimulate  autologous T-cell 
proliferation. It is important to note that cryopreservation of B cells did not impair 
their capacity to stimulate an autologous MLR.  Thus cryopreserved T  and  B cells 
from two normal subjects were not altered in their ability to generate an autologous 
MLR (Table II). 
The  impaired  stimulatory  capacity  of B  cells  could  be  a  result  of the  loss  of 
stimulatory  determinants,  the  loss  of a  stimulatory  subpopulation  of cells,  or  the 
presence of suppressor activity in the acute-phase B-cell preparation. 
Suppressor  activity  of the  acute-phase  B-cell  preparation  from  one  patient  was 
assayed.  2  A  sufficient  number  of  acute-phase  B  cells  from  this  individual  were 
cryopreserved to permit a B-cell mixture experiment. Autologous T cells were cultured 
with  convalescent  B  cells,  acute-phase  B  cells,  or  a  mixture  of  acute-phase  and 
A second patient with IM has been studied with the same results found. MOODY,  CASAZZA, CHRISTENSON, AND  WEKSLER  1451 
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FIG.  1.  Recovery of the auto]ogous  MLR  during convalescence from acute [M. The autologous 
MLR was measured at the time of diagnosis and at intervals up to 16 wE after diagnosis in seven 
patients.  1 ×  l0  B  T lymphocytes were incubated with 1 ×  105 autologous irradiated  (3,000 rad) B 
lymphocytes for 6 d. Thymidine incorporation was measured during the last 24 h. Average counts 
per minute of triplicate cultures are given. The hatched area represents the mean ±  SE of seven 
healthy control subjects. The seven individual patients are indicated by the symbols ×, A, &, I-I, 
• , 0, and O. 
convalescent  B  cells  (Table  III).  Equal  numbers  (1  ×  105) of  acute-phase  and 
convalescent  B  cells were mixed just  before their  addition  to  1 ×  105 responding T 
cells. Acute-phase B cells from this patient did not suppress the proliferative response 
of T  cells cultured with convalescent B cells, although these acute-phase B cells failed 
to stimulate an autologous MLR. 
Lymphocytotoxic antibodies and immune complexes reported to occur in acute IM 
might impair the autologous MLR.  Preincubation  of the lymphocytes from subjects 
with IM under conditions that usually clear the lymphocyte surface of these ligands 
did  not increase  the stimulatory capacity of these cells.  However,  data  obtained  by 
incubating normal autologous T  and B lymphocytes in sera from patients with acute 
IM demonstrated statistically significant inhibition of the autologous MLR. Thus, in 
six separate  experiments  the autologous MLR  was depressed  49%  (P <  0.05)  in the 
presence of serum from patients with acute IM as compared with serum from normal 
individuals. In contrast, allogeneic MLR and the PHA response were not significantly 
depressed  (2 and  15%, respectively)  by sera from patients with acute IM. 
Normal Autologous MLR in Subjects Inoculated with Live Rubella  Vaccine.  The impaired 
autologous MLR  in patients with acute IM might reflect the effect of viral infection. 
The effect of inoculation with attenuated  rubella  virus on the autologous MLR  was 
measured in four females and one male. These five subjects without evidence of prior 
immunity to rubella were inoculated with live attenuated  rubella vaccine (HPV-77). 
3-21  d  later,  autologous  MLR  were  performed.  Three  of  the  five  subjects  had 
symptoms of viral infection during this period. The autologous MLR  was normal in 
all  the  subjects  studied  (Table  IV)  and  was  not  significantly  different  from  that 
observed in normal individuals  (Table I). In contrast, the response to stimulation with 
PHA was significantly impaired  (P <  0.01)  7 and  14 d after inoculation of live rubella 1452  AUTOLOGOUS  MIXED  LYMPHOCYTE  REACTIVITY  IN  MONONUCLEOSIS 
TABLE  II 
Cellular Basis of the Impaired  Autologous MLR in Patients  with IM* 
Subject  Responding T  cell 
Stimulating B cell 
Cryopre-  Fresh 
served 
cprn/culture ×  t0 -3 
Patient A  Acute phase  0.7  6.5 
Convalescent  0.3  5.1 
Patient B  Acute phase  1.3  13.3 
Convalescent  6.6  20.8 
Patient C  Acute phase  0.1  14.7 
Convalescent  0.1  9.5 
Patient D  Acute phase  0.3  12.8 
Convalescent  0.1  18.9 
Control X  Cryopreserved  14.2  15.6 
Fresh  14.0  17.6 
Control Y  Cryopreserved  10.9  12.3 
Fresh  12.7  12.4 
* l0  s T  lymphocytes were incubated with 10  ~ irradiated autologous B lympho- 
cytes in 0.2 ml RPMI-1640 with 20% human AB serum for 6  d.  Tritiated 
thymidine incorporation was measured during the last 24 h of incubation. T 
and  B  cells from patients with  acute IM  and  from healthy controls were 
eryopreserved  in  liquid  nitrogen  for  the  same period  of time.  When  the 
autologous MLR of patients had returned to norma~.,  cryopreserved T  and 
B cells (used as responding or stimulating cells, respectively) were cultured 
together or with freshly isolated autologous T  or B cells. Cryopreserved cells 
were obtained from patients with acute,IM.  Fresh cells were obtained from 
these patients during convalescence. 
vaccine.  Subjects were subsequently retested  for immunity to the rubella virus and 
were found to have developed HI antibodies. 
Discussion 
Transient  depression of both cell-mediated and humoral  immunity follows many 
viral  infections  (9).  In  1908,  Von  Pirquet  (10)  reported  that  a  child  with  measles 
showed a  transient  depression of the tuberculin  skin reaction.  Brody and McAlister 
(11)  reported  in  1964  that  the  tuberculin  reaction  was  transiently  depressed  after 
administration of attenuated or killed measles (rubeola) vaccines. Lymphocytes from 
patients with a  variety of viral diseases have a  depressed response to PHA and other 
mitogens (12-16). 
Infectious  mononucleosis  follows  infection  with  the  Epstein-Barr  virus  (EBV). 
Patients with IM have been found to have depressed cell-mediated immunity mani- 
fested  by a  loss  of cutaneous  hypersensitivity to  tuberculin  in  vivo  (17,  18)  and  a 
depressed response to PHA (15)  and to allogeneic lymphocytes (19)  in vitro. 
The studies  reported  here demonstrate  that  the  autologous  MLR  is  impaired  in 
patients with acute IM. The normal autologous MLR returns during convalescence. 
It  is  possible  that  convalescence  may  be  associated  with  the  reestablishment  of a 
normal autologous MLR. It is of note that  in patients in whom convalescence from 
EBV infection is very much prolonged, profound alterations in lymphocyte function 
have been observed (20,  21). 
Our  studies  examined  the  cellular  basis  of the  impaired  autologous  MLR.  We MOODY,  CASAZZA, CHRISTENSON,  AND  WEKSLER 
TABLE  III 
Failure to Demonstrate Suppressor Activity in a  B-Cell Preparation from a patient with IM* 
1453 
Stimulating B lymphocyte 
Subject  Responding T  lympho-  Cryopre- 
cyte  Cryopre-  Fresh  served and 
served  fresh 
cpm/culture  X  10 -s 
Patient D  Acute phase  0.6  7.8  7.9 
Convalescent  0.6  8.7  6.1 
Control Y  Cryopreserved  13.1  l 2.8  12.9 
Fresh  13.6  14.5  10.1 
* 105 T  lymphocytes were incubated with irradiated autologous B lymphocytes in 0.2 ml 
RPMI-1640 with 20% human AB serum for 6 d. Tritiated thymidine incorporation was 
measured during the last 24 h of incubation. T  and B cells from patients with acute IM 
and from healthy controls were cryopreserved in liquid nitrogen for the same period of 
time. When the autologous MLR of patients had returned to normal, cryopreserved T and 
B cells (used as responding or stimulating cells, respectively) were cultured together or with 
freshly isolated autologous T or B cells. The cryopreserved cells were obtained from patients 
with acute IM.  Fresh cells  were obtained from the same patients during convalescence. 
Stimulating B lymphocytes were either 2 ×  105 cryopreserved cells,  2 X  105 convalescent 
cells, or 1 ×  105 cryopreserved +  1 ×  l05 convalescent cells. 
TABLE IV 
T-Lymphocyte Responses of Humans Inoculated with Rubella  Vaccine * 
Stimulus  T-lymphocytes from vac- 
cinated donors (Days 
after Inoculation)  Autologous B lympho-  PHA 
cyte 
cpm/culture  ×  10 -3 
3 d (3)  16.1 ±  4.1  38.4 ±  9.6 
7 d  (4)  12.9 ±  4.0  17.9 +  4.3 
14 d (5)  14.4 ±  4.1  21.7 4- 7.9 
21 d (4)  15.1 4- 2.0  44.7 ±  13.2 
* 105 T lymphocytes were incubated with 105 irradiated autologous B lympho- 
cytes or PHA (10 ktg/ml)  in 0.2 ml RPMI-1640 with 20% human AB serum 
for 6 or 4 d, respectively. Tritiated thymidine incorporation was measured 
during the last 24 h of culture. Counts per minute given are the mean 4- SE. 
Subjects inoculated with live rubella vaccine lacked detectable immunity to 
virus before inoculation and developed detectable HI antibodies upon re- 
testing 2-4 mo after inoculation. 
found  B  lymphocytes  from  patients  with  acute  IM  do not  stimulate  proliferation of 
autologous T  lymphocytes.  No evidence for suppressor activity in the B-cell prepara- 
tion  was  demonstrated.  In  contrast  to  the  impaired  stimulatory  capacity  of  B 
lymphocytes,  T  lymphocytes  from  patients with  IM  respond  normally  to autologous 
and to allogeneic B  lymphocytes.  Furthermore,  we found, as reported  previously, that 
the response  to  PHA  is  impaired  in  patients  with  acute  IM.  During  convalescence, 
the  PHA  response  returns  to  normal.  In  contrast,  the  autologous  MLR  was  not 
depressed  in  five  patients  inoculated  with  live rubella  vaccine.  We  did  confirm  the 
impaired  response to PHA  of lymphocytes  from subjects inoculated with rubella  (16). 
Thus,  an  impairment  in  the autologous  MLR  is not  a  feature of all viral  infections. 
The  immunoregulatory  function  of the autologous  MLR  has been  suggested  by a 1454  AUTOLOGOUS MIXED LYMPHOCYTE REACTIVITY IN MONONUCLEOSIS 
number  of  investigators  (1,  6).  The  impaired  autologous  MLR  in  patients  who 
manifest autoimmune phenomena support this hypothesis (22, 23). Additional support 
comes  from  the  finding  that  T  cells  activated  in  the  autologous  MLR  express 
suppressor  activity.  Thus,  cells  generated  in  the  autologous  MLR  suppress  T-cell 
proliferation and the generation of cytotoxic T  cells (6)  and the induction of plaque- 
forming cells (24).  Recently, Sakane and Green (5) have reported that suppressor cells 
induced by concanavalin A are drawn from the population ofT cells activated in the 
autologous MLR. 
As  the  normal  autologous  MLR  may  be  an  important  means  of  generating 
suppressor  cells,  the  appearance  of autoantibodies  in  IM  may  be  related  to  the 
impaired  MLR in  these patients.  Anti-i,  the main cause of autoimmune  hemolysis 
that occasionally complicates IM, autoantibodies to B and T lymphocytes, rheumatoid 
factors, and  antinuclear  antibodies  have all been observed in  IM  (7).  It is  possible 
that  the production  of lymphocytotoxic antibodies or immune complexes (8)  might 
contribute to the depression of cell-mediated immune responses and the impairment 
of the autologous MLR.  One of the autoantibodies  reported  to occur in  IM has B- 
lymphocyte specificity (25).  Our finding that  serum from patients with  IM inhibits 
the autologous, but not the allogeneic, MLR suggests a possible role for serum factors 
in the impaired autologous MLR in IM. It is possible that anti-B-cell antibodies block 
the autostimulatory capacity of a  subset of B cells which stimulate autologous T-cell 
proliferation.  Alternately,  EBV  infection  of  B  lymphocytes  (26)  may  alter  their 
autostimulatory capacity. 
Summary 
The autologous mixed lymphocyte reaction (MLR) is severely impaired in patients 
with  acute  infectious mononucleosis.  Reactivity returned  during  the course of con- 
valescence.  The  allogeneic  MLR  was  not  impaired  in  these  patients.  B  cells  from 
patients with infectious mononucleosis do not stimulate autologous T-cell prolifera- 
tion,  and  this  observation  appears  to  explain  the  cellular  basis  of the  impaired 
autologous MLR in infection. Two explanations for the B-cell defect were considered: 
(a) the influence of serum factors on B-cell function and (b) the effect of Epstein-Barr 
virus infection. 
Received  for publication 27 August  1979. 
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